Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kellman, Y-Prime in Strategic Partnership | Contract Pharma

What are you searching for?

Sign in
Breaking News

Kellman, Y-Prime in Strategic Partnership

To develop clinical e-MVR tools

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kellman Pharmaceutical Services (KPS) has entered a strategic alliance with Y-Prime, a provider of clinical trial management services and software. The two companies will collaborate to develop clinical e-MVR tools, which will be introduced later this year.

“Our new suite of web integrated clinical reporting tools, incorporates decades of trial monitoring experience and metrics that KPS uses for monitoring visit reporting,” said Y-Prime chief executive Shawn Blackburn. “We’re building their best practices into a suite of tools that they will be able to offer their clients for centralized management across a number of studies as a competitive advantage and will leverage their expertise for our own product offerings as well.”

“We’re extremely excited about this collaboration and have worked closely with the Y-Prime team over in recent months leading up to this announcement,” said KPS chief executive officer David Kelly. “Their products are used by major pharma companies worldwide and it’s a great validation of our distinct capabilities that they’ve selected us as a partner.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics